Literature DB >> 9373137

Identification and sequence of human PKY, a putative kinase with increased expression in multidrug-resistant cells, with homology to yeast protein kinase Yak1.

D A Begley1, M B Berkenpas, K E Sampson, I Abraham.   

Abstract

We have previously shown that several protein kinases are present in higher activity levels in multidrug resistant cell lines, such as KB-V1. We have now isolated a gene that codes for a putative protein kinase, PKY, of over 130 kDa that is expressed at higher levels in multidrug-resistant cells. RNA from KB-V1 multidrug-resistant cells was reverse-transcribed and amplified by using primers derived from consensus regions of serine threonine kinases and amplified fragments were used to recover overlapping clones from a KB-V1 cDNA library. An open reading frame of 3648 bp of DNA sequence predicting 1215 aa, has been identified. This cDNA hybridizes to a mRNA of about 7 kb which is expressed at high levels in human heart and muscle tissue and overexpressed in drug-resistant KB-V1 and HL60/ADR cells. Because its closest homolog is the yeast serine/threonine kinase, Yak1, we have called this gene PKY. PKY is also related to the protein kinase family that includes Cdks, Gsk-3, and MAPK proline-directed protein kinases. This protein represents the first of its type known in mammals and may be involved in growth control pathways similar to those described for Yak1, as well as possibly playing a role in multidrug resistance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373137     DOI: 10.1016/s0378-1119(97)00350-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1.

Authors:  Y H Kim; C Y Choi; Y Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Activation of androgen receptor function by a novel nuclear protein kinase.

Authors:  A M Moilanen; U Karvonen; H Poukka; O A Jänne; J J Palvimo
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

3.  MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures.

Authors:  Andrea Zangrando; Marta Campo Dell'orto; Geertruy Te Kronnie; Giuseppe Basso
Journal:  BMC Med Genomics       Date:  2009-06-23       Impact factor: 3.063

4.  Short intronic repeat sequences facilitate circular RNA production.

Authors:  Dongming Liang; Jeremy E Wilusz
Journal:  Genes Dev       Date:  2014-10-03       Impact factor: 11.361

5.  miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma.

Authors:  Meng Xu; Hua Jin; Cheng-Xiong Xu; Bo Sun; Zhi Mao; Wen-Zhi Bi; Yan Wang
Journal:  Oncotarget       Date:  2014-10-15

6.  Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs.

Authors:  Qiupeng Zheng; Chunyang Bao; Weijie Guo; Shuyi Li; Jie Chen; Bing Chen; Yanting Luo; Dongbin Lyu; Yan Li; Guohai Shi; Linhui Liang; Jianren Gu; Xianghuo He; Shenglin Huang
Journal:  Nat Commun       Date:  2016-04-06       Impact factor: 14.919

Review 7.  The Emerging Role of Circular RNAs in Hepatocellular Carcinoma.

Authors:  Li-Peng Qiu; Yi-Hang Wu; Xiao-Feng Yu; Qi Tang; Liang Chen; Ke-Ping Chen
Journal:  J Cancer       Date:  2018-04-12       Impact factor: 4.207

8.  Downstream Effectors of ILK in Cisplatin-Resistant Ovarian Cancer.

Authors:  Jeyshka M Reyes-González; Blanca I Quiñones-Díaz; Yasmarie Santana; Perla M Báez-Vega; Daniel Soto; Fatima Valiyeva; María J Marcos-Martínez; Ricardo J Fernández-de Thomas; Pablo E Vivas-Mejía
Journal:  Cancers (Basel)       Date:  2020-04-04       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.